BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 22305969)

  • 1. Metabolomics: a tool for early detection of toxicological effects and an opportunity for biology based grouping of chemicals-from QSAR to QBAR.
    van Ravenzwaay B; Herold M; Kamp H; Kapp MD; Fabian E; Looser R; Krennrich G; Mellert W; Prokoudine A; Strauss V; Walk T; Wiemer J
    Mutat Res; 2012 Aug; 746(2):144-50. PubMed ID: 22305969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The sensitivity of metabolomics versus classical regulatory toxicology from a NOAEL perspective.
    van Ravenzwaay B; Montoya GA; Fabian E; Herold M; Krennrich G; Looser R; Mellert W; Peter E; Strauss V; Walk T; Kamp H
    Toxicol Lett; 2014 May; 227(1):20-8. PubMed ID: 24657160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials
    Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reproducibility and robustness of metabolome analysis in rat plasma of 28-day repeated dose toxicity studies.
    Kamp H; Strauss V; Wiemer J; Leibold E; Walk T; Mellert W; Looser R; Prokoudine A; Fabian E; Krennrich G; Herold M; van Ravenzwaay B
    Toxicol Lett; 2012 Nov; 215(2):143-9. PubMed ID: 23103988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of in vivo metabolomics to preclinical/toxicological studies: case study on phenytoin-induced systemic toxicity.
    Kamp H; Fabian E; Groeters S; Herold M; Krennrich G; Looser R; Mattes W; Mellert W; Prokoudine A; Ruiz-Noppinger P; Strauss V; Walk T; Wiemer J; van Ravenzwaay B
    Bioanalysis; 2012 Sep; 4(18):2291-301. PubMed ID: 23046269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanistic analysis of metabolomics patterns in rat plasma during administration of direct thyroid hormone synthesis inhibitors or compounds increasing thyroid hormone clearance.
    Montoya GA; Strauss V; Fabian E; Kamp H; Mellert W; Walk T; Looser R; Herold M; Krennrich G; Peter E; van Ravenzwaay B
    Toxicol Lett; 2014 Mar; 225(2):240-51. PubMed ID: 24370789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of metabolomics for the discovery of new biomarkers of effect.
    van Ravenzwaay B; Cunha GC; Leibold E; Looser R; Mellert W; Prokoudine A; Walk T; Wiemer J
    Toxicol Lett; 2007 Jul; 172(1-2):21-8. PubMed ID: 17614222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nutritional impact on the plasma metabolome of rats.
    Mellert W; Kapp M; Strauss V; Wiemer J; Kamp H; Walk T; Looser R; Prokoudine A; Fabian E; Krennrich G; Herold M; van Ravenzwaay B
    Toxicol Lett; 2011 Nov; 207(2):173-81. PubMed ID: 21907771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative analysis of predictive models for nongenotoxic hepatocarcinogenicity using both toxicogenomics and quantitative structure-activity relationships.
    Liu Z; Kelly R; Fang H; Ding D; Tong W
    Chem Res Toxicol; 2011 Jul; 24(7):1062-70. PubMed ID: 21627106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Substance-tailored testing strategies in toxicology: an in silico methodology based on QSAR modeling of toxicological thresholds and Monte Carlo simulations of toxicological testing.
    Péry AR; Desmots S; Mombelli E
    Regul Toxicol Pharmacol; 2010 Feb; 56(1):82-92. PubMed ID: 19766156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of rodent carcinogenic potential of naturally occurring chemicals in the human diet using high-throughput QSAR predictive modeling.
    Valerio LG; Arvidson KB; Chanderbhan RF; Contrera JF
    Toxicol Appl Pharmacol; 2007 Jul; 222(1):1-16. PubMed ID: 17482223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toxicogenomics concepts and applications to study hepatic effects of food additives and chemicals.
    Stierum R; Heijne W; Kienhuis A; van Ommen B; Groten J
    Toxicol Appl Pharmacol; 2005 Sep; 207(2 Suppl):179-88. PubMed ID: 16139318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utility of in vivo metabolomics to support read-across for UVCB substances under REACH.
    Kamp H; Kocabas NA; Faulhammer F; Synhaeve N; Rushton E; Flick B; Giri V; Sperber S; Higgins LG; Penman MG; van Ravenzwaay B; Rooseboom M
    Arch Toxicol; 2024 Mar; 98(3):755-768. PubMed ID: 38265474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The enhancement of the subacute repeat dose toxicity test OECD TG 407 for the detection of endocrine active chemicals: comparison with toxicity tests of longer duration.
    Gelbke HP; Hofmann A; Owens JW; Freyberger A
    Arch Toxicol; 2007 Apr; 81(4):227-50. PubMed ID: 17047927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. On the nature, evolution and future of quantitative structure-activity relationships (QSAR) in toxicology.
    Veith GD
    SAR QSAR Environ Res; 2004; 15(5-6):323-30. PubMed ID: 15669692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Creation of a digital slide and tissue microarray resource from a multi-institutional predictive toxicology study in the rat: an initial report from the PredTox group.
    Mulrane L; Rexhepaj E; Smart V; Callanan JJ; Orhan D; Eldem T; Mally A; Schroeder S; Meyer K; Wendt M; O'Shea D; Gallagher WM
    Exp Toxicol Pathol; 2008 Aug; 60(4-5):235-45. PubMed ID: 18479893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemical structure of mutagens and carcinogens and the relationship with biological activity.
    Benigni R
    J Exp Clin Cancer Res; 2004 Mar; 23(1):5-8. PubMed ID: 15149144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. QSAR prediction of estrogen activity for a large set of diverse chemicals under the guidance of OECD principles.
    Liu H; Papa E; Gramatica P
    Chem Res Toxicol; 2006 Nov; 19(11):1540-8. PubMed ID: 17112243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EU framework 6 project: predictive toxicology (PredTox)--overview and outcome.
    Suter L; Schroeder S; Meyer K; Gautier JC; Amberg A; Wendt M; Gmuender H; Mally A; Boitier E; Ellinger-Ziegelbauer H; Matheis K; Pfannkuch F
    Toxicol Appl Pharmacol; 2011 Apr; 252(2):73-84. PubMed ID: 20955723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sensitive detection of the endocrine effects of the estrogen analogue ethinylestradiol using a modified enhanced subacute rat study protocol (OECD Test Guideline no. 407).
    Andrews P; Freyberger A; Hartmann E; Eiben R; Loof I; Schmidt U; Temerowski M; Folkerts A; Stahl B; Kayser M
    Arch Toxicol; 2002 May; 76(4):194-202. PubMed ID: 12029382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.